APA (7th ed.) Citation

Zheng, J., Wheeler, E., Pietzner, M., Andlauer, T. F. M., Yau, M. S., Hartley, A. E., . . . Tobias, J. H. (2023). Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & rheumatology, 75(10), . https://doi.org/10.1002/art.42538

Chicago Style (17th ed.) Citation

Zheng, Jie, et al. "Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence from a Genome-wide Association Meta-analysis Followed by Mendelian Randomization." Arthritis & Rheumatology 75, no. 10 (2023). https://doi.org/10.1002/art.42538.

MLA (9th ed.) Citation

Zheng, Jie, et al. "Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence from a Genome-wide Association Meta-analysis Followed by Mendelian Randomization." Arthritis & Rheumatology, vol. 75, no. 10, 2023, https://doi.org/10.1002/art.42538.